According to a Wall Street Journal report, the preferred Covid-19 shot globally is the Pfizer-BioNTech vaccine.

The controversy surrounding Covid-19’s origin continues to heat up, as the National Institutes of Health’s recent removal of genetic data about the novel coronavirus virus from the NIH archive was brought into the spotlight.

The U.S. Food and Drug Administration said on Sept. 9 the regulatory agency needs more time to decide whether e-cigarette maker Juul Labs Inc. and other major manufacturers can sell their products in the United States.

Pfizer Inc. on Aug. 25 said a booster dose of the company’s two-shot Covid-19 vaccine spurs a more than threefold increase in antibodies against the coronavirus, as the drugmaker seeks U.S. regulatory approval for a third injection.

U.S. health regulators could approve a third Covid-19 shot for adults beginning at least six months after full vaccination, instead of the previously announced eight-month gap, the Wall Street Journal reported on Aug. 25.

The first human case of a new strain of avian flu was diagnosed in China in late May. Chinese health authorities say there is a low risk of contagion. After China notoriously underreported COVID-19 mortality, can this new assurance be trusted?

A report on the origins of Covid-19 by a U.S. government national laboratory concluded that the hypothesis of a virus leak from a Chinese lab in Wuhan is plausible and deserves further investigation, the Wall Street Journal said on June 7, citing people familiar with the classified document.

Thermo Fisher Scientific Inc. is acquiring contract researcher PPD Inc. for $17.4 billion as the medical device maker adds more muscle to the company’s pharmaceutical services business.

The United States identified three online publications directed by Russia’s intelligence services that it says are seeking to undermine Covid-19 vaccines produced by Pfizer and Moderna, a State Department spokeswoman said.

U.S. scientists are skeptical of a one-shot regimen for Pfizer Inc. and Moderna Inc. Covid-19 vaccines, saying there is not enough evidence that a single dose provides long-term protection, the Wall Street Journal reported.